BlackRock, Inc. 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | VistaGen Therapeutics, Inc. VTGN |
BlackRock Inc. BLK |
0 0.000% |
-408,932 (Position Closed) |
Filing |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
BlackRock Inc. BLK |
408,932 5.900% |
12,459 (+3.14%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
BlackRock Inc. BLK |
396,473 6.000% |
396,473 (New Position) |
Filing |